Radio and TV personality, Jody Vance, speaks with Steve Saviuk, president and CEO of Valeo Pharma (VPH.C) to get a close look at the company and it’s product pipeline including Hesperco, an immune support anti-oxidant currently involved in clinical trials at the Montreal Heart Institute. What could this mean for investors? Tune in!



Written By:

Equity Guru

More By This Author